Physician profile
Daniel Sullivan
NPI 1154983740
$21,662.34
in general payments reported to CMS, 2019-2025
20 companies · $5,730 in 2025
The $5,730 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $144 · 2021: $3,948 · 2022: $316 · 2023: $2,570 · 2024: $8,016 · 2025: $5,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,295 · Food and Beverage: $4,081 · Travel and Lodging: $2,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,295.00 |
| Food and Beverage | $4,080.71 |
| Travel and Lodging | $2,940.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,535.91 | 2024-2025 | Evos, Real Intelligence, Twinfix |
| Medical Device Business Services, INC. | $4,005.76 | 2019-2025 | Va-Lcp, Actis |
| Pinnacle, INC | $3,546.23 | 2019-2024 | |
| Stryker Corporation | $2,623.26 | 2022-2025 | Mako, Am, Triathlon |
| Zimmer Biomet Holdings, INC. | $2,508.74 | 2021-2025 | Persona, Arcos, Comprehensive Shoulder System |
| Maxx Orthopedics, INC. | $197.84 | 2023 | |
| Depuy Synthes Sales INC. | $170.26 | 2020-2025 | Actis, Na, Fibulink |
| Linvatec Corporation | $147.13 | 2024 | Biobrace 23mm |
| Medacta USA, INC. | $130.64 | 2021-2022 | |
| Baxter Healthcare | $114.78 | 2020 | |
| Heron Therapeutics, INC. | $113.59 | 2022 | |
| Kci USA, INC. | $113.09 | 2022-2023 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Avita Medical Americas, LLC | $106.84 | 2024 | |
| Flower Orthopedics Coporation | $98.62 | 2025 | |
| Ossdsign USA Incorporated | $84.12 | 2025 | Ossdsign Catalyst |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medical, LLC | $72.85 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $33.62 | 2023-2024 | Iovera, Exparel, Zilretta |
| Vertex Pharmaceuticals Incorporated | $26.05 | 2025 | |
| Amgen INC. | $19.17 | 2025 | Krystexxa |
| Endo Pharmaceuticals INC. | $13.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.